174 related articles for article (PubMed ID: 33902031)
41. A comparison of post-transplant renal function in pre-emptive and post-dialysis pediatric kidney transplant recipients.
Kim JK; Lorenzo AJ; Farhat WA; Chua ME; Ming JM; Dos Santos J; Koyle MA
Pediatr Transplant; 2019 May; 23(3):e13377. PubMed ID: 30735602
[TBL] [Abstract][Full Text] [Related]
42. Diagnosis value of SARS-CoV-2 antigen/antibody combined testing using rapid diagnostic tests at hospital admission.
Veyrenche N; Bolloré K; Pisoni A; Bedin AS; Mondain AM; Ducos J; Segondy M; Montes B; Pastor P; Morquin D; Makinson A; Le Moing V; Van de Perre P; Foulongne V; Tuaillon E
J Med Virol; 2021 May; 93(5):3069-3076. PubMed ID: 33554363
[TBL] [Abstract][Full Text] [Related]
43. The kinetics of viral load and antibodies to SARS-CoV-2.
Sun J; Tang X; Bai R; Liang C; Zeng L; Lin H; Yuan R; Zhou P; Huang X; Xiong Q; Peng J; Cui F; Ke B; Su J; Liu Z; Lu J; Tian J; Sun R; Ke C
Clin Microbiol Infect; 2020 Dec; 26(12):1690.e1-1690.e4. PubMed ID: 32898715
[TBL] [Abstract][Full Text] [Related]
44. Hemodialysis patients with coronavirus disease 2019: reduced antibody response.
Beppu H; Fukuda T; Kawanishi T; Yasui F; Toda M; Kimura H; Nakamura Y; Nakamura Y; Kojima K; Ogawa H; Ishiwatari A; Kamei Y; Ogawa T; Abe Y; Endo M; Hanawa T; Mizobuchi R; Sugita C; Okamoto K; Hatakeyama S; Yamada T; Kohara M; Wakai S
Clin Exp Nephrol; 2022 Feb; 26(2):170-177. PubMed ID: 34487276
[TBL] [Abstract][Full Text] [Related]
45. Risk factors predisposing to toxoplasmosis in chronic renal failure patients and renal transplant recipients.
Mahgoub AM; Aufy SM; Saadi MG; Adel Elmallawany M
J Egypt Soc Parasitol; 2009 Dec; 39(3):963-73. PubMed ID: 20120759
[TBL] [Abstract][Full Text] [Related]
46. Characteristics of patients with coronavirus disease (COVID-19) confirmed using an IgM-IgG antibody test.
Xie J; Ding C; Li J; Wang Y; Guo H; Lu Z; Wang J; Zheng C; Jin T; Gao Y; He H
J Med Virol; 2020 Oct; 92(10):2004-2010. PubMed ID: 32330303
[TBL] [Abstract][Full Text] [Related]
47. Panel reactive antibodies in predicting hepatitis C virus treatment outcome in kidney transplant candidates.
Öcal S; Harmancı Ö; Korkmaz M; Ensaroğlu F; Çolak T; Selçuk H; Moray G; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():193-6. PubMed ID: 25894153
[TBL] [Abstract][Full Text] [Related]
48. Variation in Nonmelanoma Skin Cancer Incidence by Treatment Modality Among Patients Receiving Multiple Kidney Transplants.
Sexton DJ; O'Kelly P; O'Leary E; Murray S; Deady S; Daly F; Egan J; Houlihan DD; McCormick PA; Morris PG; Ni Raghallaigh S; Moloney FJ; O'Neill JP; Conlon PJ
JAMA Dermatol; 2019 May; 155(5):594-598. PubMed ID: 30725084
[TBL] [Abstract][Full Text] [Related]
49. COVID-19 and lombardy: TESTing the impact of the first wave of the pandemic.
Perico L; Tomasoni S; Peracchi T; Perna A; Pezzotta A; Remuzzi G; Benigni A
EBioMedicine; 2020 Nov; 61():103069. PubMed ID: 33130396
[TBL] [Abstract][Full Text] [Related]
50. Failed antibody response in a renal transplant recipient with SARS-CoV-2 infected.
Xia Z; Liu X; Hu X; Zhong Z; Wang Y; Peng G; Ye Q
Transpl Infect Dis; 2020 Oct; 22(5):e13349. PubMed ID: 32500922
[No Abstract] [Full Text] [Related]
51. Persistence of SARS-CoV-2 nasopharyngeal swab PCR positivity in COVID-19 convalescent plasma donors.
Ikegami S; Benirschke R; Flanagan T; Tanna N; Klein T; Elue R; Debosz P; Mallek J; Wright G; Guariglia P; Kang J; Gniadek TJ
Transfusion; 2020 Dec; 60(12):2962-2968. PubMed ID: 32840002
[TBL] [Abstract][Full Text] [Related]
52. Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.
Sanders JF; Messchendorp AL; de Vries RD; Baan CC; van Baarle D; van Binnendijk R; Diavatopoulos DA; Geers D; Schmitz KS; GeurtsvanKessel CH; den Hartog G; Kho MML; Koopmans MPG; van der Molen RG; Remmerswaal EBM; Rots N; Gansevoort RT; Bemelman FJ; Hilbrands LB; Reinders MEJ;
Clin Infect Dis; 2023 Feb; 76(3):e188-e199. PubMed ID: 35796536
[TBL] [Abstract][Full Text] [Related]
53. Toxoplasma antibody titers in renal transplant recipients. Pretransplant evaluation and posttransplant follow-up of 73 patients.
Derouin F; Debure A; Godeaut E; Lariviere M; Kreis H
Transplantation; 1987 Oct; 44(4):515-8. PubMed ID: 3313838
[TBL] [Abstract][Full Text] [Related]
54. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
55. Role of Screening for COVID-19 in Hemodialysis Wards, Results of a Single Center Study.
Ossareh S; Bagheri M; Abbasi M; Abolfathi S; Bohlooli A
Iran J Kidney Dis; 2020 Sep; 14(5):389-398. PubMed ID: 32943594
[TBL] [Abstract][Full Text] [Related]
56. A comparison of antibody response in kidney transplant recipients and healthcare workers who had PCR-confirmed COVID-19 infection.
Dincer MT; Eren N; Murt A; Yıldız N; Özcan ŞG; Ergül M; Bek SG; Atlı Z; Trabulus S; Dervişoğlu E; Doğanay HL; Seyahi N
Turk J Med Sci; 2022 Dec; 52(6):1754-1761. PubMed ID: 36945967
[TBL] [Abstract][Full Text] [Related]
57. Anti-SARS-CoV-2 IgG antibody titer after BNT162b2 mRNA COVID-19 vaccination in Japanese patients who underwent renal replacement therapy, hemodialysis, peritoneal dialysis, and kidney transplantation.
Iwabuchi R; Harada M; Yamada A; Aomura D; Yamada Y; Sonoda K; Nakazawa H; Sakai K; Mizukami E; Hashimoto K; Kamijo Y
Clin Exp Nephrol; 2023 Aug; 27(8):660-671. PubMed ID: 37095343
[TBL] [Abstract][Full Text] [Related]
58. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
Shu H; Wang S; Ruan S; Wang Y; Zhang J; Yuan Y; Liu H; Wu Y; Li R; Pan S; Ouyang Y; Yuan S; Zhou P; Shang Y
Virol Sin; 2020 Dec; 35(6):744-751. PubMed ID: 32720214
[TBL] [Abstract][Full Text] [Related]
59. Antibody tests for identification of current and past infection with SARS-CoV-2.
Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
[TBL] [Abstract][Full Text] [Related]
60. The humoral immune response to the BNT 162B2 vaccine in pediatrics on renal replacement therapy.
Alshami A; Bahbah H; Al Attas R; Aldokhi F; Azzam A
Pediatr Transplant; 2024 May; 28(3):e14712. PubMed ID: 38553800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
